Exposure to a Patient-Centered, Web-Based Intervention for Managing Cancer Symptom and Quality of Life Issues: Impact on Symptom Distress

Abstract

BackgroundEffective eHealth interventions can benefit a large number of patients with content intended to support self-care and management of both chronic and acute conditions. Even though usage statistics are easily logged in most eHealth interventions, usage or exposure has rarely been reported in trials, let alone studied in relationship to effectiveness.ObjectiveThe intent of the study was to evaluate use of a fully automated, Web-based program, the Electronic Self Report Assessment-Cancer (ESRA-C), and how delivery and total use of the intervention may have affected cancer symptom distress.MethodsPatients at two cancer centers used ESRA-C to self-report symptom and quality of life (SxQOL) issues during therapy. Participants were randomized to ESRA-C assessment only (control) or the ESRA-C intervention delivered via the Internet to patients’ homes or to a tablet at the clinic. The intervention enabled participants to self-monitor SxQOL and receive self-care education and customized coaching on how to report concerns to clinicians. Overall and voluntary intervention use were defined as having ≥2 exposures, and one non-prompted exposure to the intervention, respectively. Factors associated with intervention use were explored with Fisher’s exact test. Propensity score matching was used to select a sample of control participants similar to intervention participants who used the intervention. Analysis of covariance (ANCOVA) was used to compare change in Symptom Distress Scale (SDS-15) scores from pre-treatment to end-of-study by groups in the matched sample.ResultsRadiation oncology participants used the intervention, overall and voluntarily, more than medical oncology and transplant participants. Participants who were working and had more than a high school education voluntarily used the intervention more. The SDS-15 score was reduced by an estimated 1.53 points (P=.01) in the intervention group users compared to the matched control group.ConclusionsThe intended effects of a Web-based, patient-centered intervention on cancer symptom distress were modified by intervention use frequency. Clinical and personal demographics influenced voluntary use.Trial RegistrationClinicaltrials.gov NCT00852852; http://clinicaltrials.gov/ct2/show/NCT00852852 (Archived by WebCite at http://www.webcitation.org/6YwAfwWl7).

Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes

“…It is known that educational materials and delivery methods should be objective and accurate because patients undergoing transplantation tend to overestimate the benefits of BMT . Successful education has been associated with decreased distress and increased patient satisfaction by better preparing patients for the transplantation process. Although to our knowledge not formally assessed in the current literature, regret among patients undergoing transplantation likely may stem from education that is not appropriately tailored to the cultural background, barriers to learning, and preferential learning styles of these individuals .…”

Self-Care Support for Patients with Gastrointestinal Cancer: iCancerHealth

“…Based on our previous experience with remote access to a symptom reporting and self-care instruction intervention in which 34% voluntarily (unprompted) accessed the Web-based application, 28 we considered use of iCancerHealth feasible if at least a 34% remote access rate was reached. The remote access rate was defined as accessing and using iCancerHealth from a nonclinic location at least once.…”

Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project

“…However, health care providers have not kept pace in developing the design of their management packages for cancer patients to fit the model of care for chronic diseases [1,2]. An important aspect of the chronic diseases model of care is delivery of treatment and review of symptoms assessed in the patient’s home and usual environment [4-8]. To best achieve this goal in cancer patients receiving often complex and toxic multidrug chemotherapy, it is important that the care model integrates the need for adequate safety [4,9,10].…”